Your Body Already Knows How to Regrow Limbs—We Just Have to Stop the Scarring

Here’s a thought: what if your body has been capable of regrowing lost limbs all along, and we’ve just been getting in our own way?

That’s essentially what researchers at Texas A&M University have discovered in a groundbreaking study published in Nature Communications. For decades, scientists have puzzled over why some animals—salamanders, for instance—can regenerate entire body parts while humans default to forming scar tissue instead. Dr. Ken Muneoka, a professor in the Texas A&M College of Veterinary Medicine and Biomedical Sciences, has spent his career chasing this question, and now he and his colleagues believe they’ve found a workable answer.

The problem isn’t that we lack the biological machinery. It’s that when we get injured, our bodies prioritize speed over quality. Fibroblast cells rush to seal the wound with scar tissue—a smart survival move in the short term, but one that locks us out of actual regeneration. Salamanders don’t do this. Instead, those same types of cells organize into a structure called a blastema, which allows the body to rebuild what was lost. The key insight: those cells can go either direction. They’re not choosing differently than us—they’re choosing at all.

Muneoka’s team developed a two-step approach using two growth factors that were already well-studied. First, they applied fibroblast growth factor 2 (FGF2) after a wound had healed, essentially telling the body to stop making scar tissue and start making something regenerative instead. Days later, they added bone morphogenetic protein 2 (BMP2)—essentially instructions for what to build. In mice, this worked. Bone, ligaments, tendons, and joint structures regenerated. They weren’t perfect replicas of the original anatomy, but they were functionally there.

Here’s what makes this genuinely exciting: the researchers didn’t need to inject stem cells from outside the body. The cells needed to do the work were already present at the injury site. All they needed was the right programming. And because BMP2 is already FDA approved for certain medical uses and FGF2 is already in multiple clinical trials, the path toward human application might be closer than it sounds.

The research is still early, and Muneoka isn’t claiming we’re on the verge of regrowing entire limbs in humans anytime soon. But even a partial shift away from scarring could transform how we approach wound healing and amputation recovery. As Muneoka put it:“Regenerative failure in mammals can be rescued. Now we have a model to begin figuring out how.”